Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumabKoichi Sato, Hiroaki Akamatsu, Eriko Murakami, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|May 22, 2009
[A case of Wegener's granulomatosis with pachymeningitis]Mio Hayakawa, Masayoshi Nishijima, Kyoko Inui, et al.
Japanese Journal of Clinical Oncology|March 29, 2019
Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance statusKazuhisa Nakashima, Madoka Kimura, Hiroaki Akamatsu, et al.
JTO Clinical and Research Reports|September 30, 2021
Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 StudyHiroaki Akamatsu, Shunsuke Teraoka, Hidetoshi Hayashi, et al.
Annals of Nuclear Medicine|December 22, 2010
18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumorsKyoichi Kaira, Haruyasu Murakami, Satoru Miura, et al.
Investigational New Drugs|May 20, 2020
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trialKazuhisa Nakashima, Yuichi Ozawa, Haruko Daga, et al.
BMC Cancer|January 16, 2014
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapyHiroaki Akamatsu, Keita Mori, Tateaki Naito, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2015
Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe ExacerbationsKazuto Matsunaga, Tsunahiko Hirano, Asako Oka, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumabJun Oyanagi, Yasuhiro Koh, Koichi Sato, et al.
American Journal of Clinical Oncology|February 8, 2013
Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancerKazushige Wakuda, Hirotsugu Kenmotsu, Tateaki Naito, et al.
Pageof 15